Cytokineticsorporated Current Ratio 2006-2018 | CYTK

Historical current ratio values for Cytokineticsorporated (CYTK) over the last 10 years.
Cytokineticsorporated Annual Current Ratio
2017 8.45
2016 4.77
2015 3.57
2014 5.50
2013 2.97
2012 10.76
2011 11.14
2010 10.04
2009 5.79
2008 2.58
2007 4.61
2006 5.82
2005 7.00
Cytokineticsorporated Quarterly Current Ratio
Q2 2018 8.95
Q1 2018 7.07
Q4 2017 8.45
Q3 2017 7.60
Q2 2017 10.21
Q1 2017 5.74
Q4 2016 4.77
Q3 2016 5.32
Q2 2016 3.68
Q1 2016 4.30
Q4 2015 3.57
Q3 2015 3.34
Q2 2015 3.71
Q1 2015 4.37
Q4 2014 5.50
Q3 2014 6.28
Q2 2014 4.73
Q1 2014 4.35
Q4 2013 2.97
Q3 2013 1.85
Q2 2013 2.75
Q1 2013 10.94
Q4 2012 10.76
Q3 2012 17.17
Q2 2012 23.30
Q1 2012 10.12
Q4 2011 11.14
Q3 2011 11.89
Q2 2011 12.68
Q1 2011 10.42
Q4 2010 10.04
Q3 2010 12.22
Q2 2010 13.11
Q1 2010 6.11
Q4 2009 5.79
Q3 2009 6.26
Q2 2009 5.90
Q1 2009 2.96
Q4 2008 2.58
Q3 2008 2.98
Q2 2008 3.58
Q1 2008 4.09
Q4 2007 4.61
Q3 2007 5.92
Q2 2007 6.48
Q1 2007 7.20
Q4 2006 5.82
Q3 2006 7.37
Q2 2006 9.16
Q1 2006 10.65
Q4 2005 7.00
Q3 2005 7.77
Q2 2005 8.81
Q1 2005 8.67
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.377B $0.013B
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or deteriorating. With an unmatched understanding of muscle biology and mechanics of muscle performance, the company is developing small molecule drug candidates engineered to increase muscle function and contractility. Cytokinetics' lead drug candidate is tirasemtiv, a fast skeletal muscle activator, for the potential treatment of ALS. Tirasemtiv has been granted orphan drug designation and fast track status by the FDA and orphan medicinal product designation by the EMA. Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a novel cardiac muscle activator, for the potential treatment of heart failure, and with Astellas Pharma Inc. to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment of spinal muscular atrophy.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $126.613B 14.53
Gilead Sciences (GILD) United States $100.039B 11.10
Biogen (BIIB) United States $68.650B 14.55
Celgene (CELG) United States $64.688B 12.92
Illumina (ILMN) United States $48.113B 60.28
Vertex Pharmaceuticals (VRTX) United States $44.736B 101.77
Regeneron Pharmaceuticals (REGN) United States $39.597B 22.26
Alexion Pharmaceuticals (ALXN) United States $26.380B 19.83
BioMarin Pharmaceutical (BMRN) United States $18.242B 0.00
Incyte (INCY) United States $13.790B 463.36
Seattle Genetics (SGEN) United States $11.719B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.361B 60.17
Alnylam Pharmaceuticals (ALNY) United States $9.156B 0.00
QIAGEN (QGEN) Netherlands $8.634B 28.23
BeiGene (BGNE) Cayman Islands $8.550B 0.00
Sarepta Therapeutics (SRPT) United States $8.451B 0.00
Bluebird Bio (BLUE) United States $8.449B 0.00
Alkermes (ALKS) Ireland $6.801B 0.00
Bio-Techne Corp (TECH) United States $6.677B 44.87
Exact Sciences (EXAS) United States $6.051B 0.00
Exelixis (EXEL) United States $5.853B 19.07
Galapagos (GLPG) Belgium $5.504B 0.00
Ligand Pharmaceuticals (LGND) United States $5.225B 46.28
Ultragenyx Pharmaceutical (RARE) United States $3.838B 0.00
Immunomedics (IMMU) United States $3.805B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.764B 0.00
Horizon Pharma Public (HZNP) Ireland $3.491B 19.76
Intercept Pharmaceuticals (ICPT) United States $3.272B 0.00
China Biologic Products (CBPO) China $3.131B 20.68
Array BioPharma (ARRY) United States $3.086B 0.00
Akcea Therapeutics (AKCA) United States $3.082B 0.00
Blueprint Medicines (BPMC) United States $3.031B 0.00
Myriad Genetics (MYGN) United States $2.973B 35.57
Medicines (MDCO) United States $2.859B 0.00
Ascendis Pharma (ASND) Denmark $2.838B 0.00
Emergent Biosolutions (EBS) United States $2.827B 22.52
ARGENX SE-ADR (ARGX) Netherlands $2.807B 0.00
Amicus Therapeutics (FOLD) United States $2.707B 0.00
Halozyme Therapeutics (HALO) United States $2.489B 33.17
Global Blood Therapeutics (GBT) United States $2.350B 0.00
MyoKardia (MYOK) United States $2.347B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.240B 0.00
Spark Therapeutics (ONCE) United States $2.198B 0.00
Acceleron Pharma (XLRN) United States $2.191B 0.00
Repligen (RGEN) United States $2.160B 72.51
REGENXBIO (RGNX) United States $2.137B 33.58
Cambrex (CBM) United States $2.007B 16.09
Momenta Pharmaceuticals (MNTA) United States $2.005B 0.00
AnaptysBio (ANAB) United States $1.958B 0.00
Genomic Health (GHDX) United States $1.927B 107.48
G1 THERAPEUTICS (GTHX) United States $1.881B 0.00
Mirati Therapeutics (MRTX) United States $1.875B 0.00
Clovis Oncology (CLVS) United States $1.825B 0.00
Arena Pharmaceuticals (ARNA) United States $1.822B 0.00
Rubius Therapeutics (RUBY) United States $1.799B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.786B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.775B 0.00
Atara Biotherapeutics (ATRA) United States $1.714B 0.00
Insmed (INSM) United States $1.685B 0.00
Reata Pharmaceuticals (RETA) United States $1.678B 0.00
Puma Biotechnology (PBYI) United States $1.665B 0.00
Aimmune Therapeutics (AIMT) United States $1.657B 0.00
Sangamo Therapeutics (SGMO) United States $1.617B 0.00
Allakos (ALLK) United States $1.591B 0.00
Myovant Sciences (MYOV) United Kingdom $1.473B 0.00
Lion Biotechnologies (IOVA) United States $1.434B 0.00
Denali Therapeutics (DNLI) United States $1.408B 0.00
IMMURON LTD (IMRN) Australia $1.406B 0.00
Innoviva (INVA) United States $1.400B 8.99
Editas Medicine (EDIT) United States $1.400B 0.00
WAVE Life Sciences (WVE) Singapore $1.369B 0.00
Solid Biosciences (SLDB) United States $1.363B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.332B 0.00
UniQure (QURE) Netherlands $1.319B 0.00
Acorda Therapeutics (ACOR) United States $1.318B 27.48
Audentes Therapeutics (BOLD) United States $1.313B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.307B 0.00
BIOHAVEN PHARM (BHVN) United States $1.303B 0.00
Coherus BioSciences (CHRS) United States $1.272B 0.00
Intellia Therapeutics (NTLA) United States $1.197B 0.00
Cellectis (CLLS) France $1.180B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.156B 0.00
Athenex (ATNX) United States $1.150B 0.00
Intra-Cellular Therapies (ITCI) United States $1.129B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.124B 2145.00
Zai Lab Unsponsored ADR (ZLAB) China $1.116B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.090B 0.00
DBV Technologies (DBVT) France $1.084B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.082B 0.00
CytomX Therapeutics (CTMX) United States $1.076B 0.00
Retrophin (RTRX) United States $1.041B 0.00
NeoGenomics (NEO) United States $1.038B 181.57
Apellis Pharmaceuticals (APLS) United States $1.037B 0.00
Revance Therapeutics (RVNC) United States $0.992B 0.00
AVROBIO (AVRO) United States $0.991B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.874B 0.00
Amarin (AMRN) Ireland $0.839B 0.00
Dynavax Technologies (DVAX) United States $0.828B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.812B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.795B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.782B 0.00
Kura Oncology (KURA) United States $0.756B 0.00
Heska (HSKA) United States $0.740B 63.69
NuCana Sponsored ADR (NCNA) United Kingdom $0.734B 0.00
Cara Therapeutics (CARA) United States $0.734B 0.00
Aptinyx (APTX) United States $0.732B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.726B 0.00
Geron (GERN) United States $0.716B 0.00
InflaRx (IFRX) Germany $0.703B 0.00
Epizyme (EPZM) United States $0.699B 0.00
UNITY Biotechnology (UBX) $0.678B 0.00
ANI Pharmaceuticals (ANIP) United States $0.675B 13.40
UROGEN PHARMA (URGN) Israel $0.637B 0.00
Eidos Therapeutics (EIDX) United States $0.632B 0.00
Sorrento Therapeutics (SRNE) United States $0.625B 0.00
Viking Therapeutics (VKTX) United States $0.622B 0.00
Abeona Therapeutics (ABEO) United States $0.618B 0.00
Anika Therapeutics (ANIK) United States $0.605B 25.45
AC Immune SA (ACIU) Switzerland $0.599B 0.00
Verastem (VSTM) United States $0.593B 0.00
Fate Therapeutics (FATE) United States $0.592B 0.00
Prothena (PRTA) Ireland $0.586B 0.00
Mesoblast (MESO) Australia $0.579B 0.00
Vericel (VCEL) United States $0.543B 0.00
Senesco Technologies (ELOX) United States $0.541B 0.00
Arbutus Biopharma (ABUS) Canada $0.535B 0.00
Replimune (REPL) United States $0.527B 0.00
Arcus Biosciences (RCUS) United States $0.526B 0.00
Kindred Biosciences (KIN) United States $0.524B 0.00
Novavax (NVAX) United States $0.520B 0.00
BeyondSpring (BYSI) United States $0.514B 0.00
MiMedx (MDXG) United States $0.510B 21.86
Five Prime Therapeutics (FPRX) United States $0.509B 0.00
ObsEva SA (OBSV) Switzerland $0.509B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.505B 0.00
Stemline Therapeutics (STML) United States $0.469B 0.00
Unum Therapeutics (UMRX) United States $0.466B 0.00
Zymeworks (ZYME) Canada $0.455B 0.00
Aduro Biotech (ADRO) United States $0.435B 0.00
Zealand Pharma (ZEAL) Denmark $0.431B 0.00
Magenta Therapeutics (MGTA) United States $0.425B 0.00
Merus (MRUS) Netherlands $0.423B 0.00
Evelo Biosciences (EVLO) United States $0.420B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.410B 0.00
Syros Pharmaceuticals (SYRS) United States $0.406B 0.00
Inovio Pharmaceuticals (INO) United States $0.404B 0.00
GTx (GTXI) United States $0.401B 0.00
Vital Therapies (VTL) United States $0.394B 0.00
MediciNova (MNOV) United States $0.392B 0.00
Albireo Pharma (ALBO) United States $0.380B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.377B 0.00
Sinovac Biotech (SVA) China $0.376B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.370B 0.00
RA PHARMCTL INC (RARX) United States $0.346B 0.00
Cellular Biomedicine (CBMG) United States $0.346B 0.00
PDL BioPharma (PDLI) United States $0.345B 4.84
Scholar Rock Holding (SRRK) United States $0.338B 0.00
Adverum Biotechnologies (ADVM) United States $0.332B 0.00
Seres Therapeutics (MCRB) United States $0.326B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.321B 0.00
ResTORbio (TORC) United States $0.319B 0.00
BioTime (BTX) United States $0.316B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.311B 0.00
Kezar Life Sciences (KZR) United States $0.308B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.306B 0.00
Kala Pharmaceuticals (KALA) United States $0.305B 0.00
Selecta Biosciences (SELB) United States $0.295B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.294B 0.00
Osiris Therapeutics (OSIR) United States $0.293B 0.00
Mersana Therapeutics (MRSN) United States $0.291B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.289B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.283B 0.00
Athersys (ATHX) United States $0.281B 0.00
Strongbridge Biopharma (SBBP) United States $0.280B 0.00
Celyad SA (CYAD) Belgium $0.278B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.277B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.276B 0.00
Kadmon Holdings (KDMN) United States $0.273B 0.00
ADMA Biologics Inc (ADMA) United States $0.273B 0.00
Constellation Pharmaceuticals (CNST) United States $0.268B 0.00
Celcuity (CELC) United States $0.263B 0.00
Cohbar (CWBR) United States $0.260B 0.00
Axovant Sciences (AXON) United Kingdom $0.253B 0.00
NantKwest (NK) United States $0.250B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.247B 0.00
MeiraGTx Holdings (MGTX) United States $0.245B 0.00
ChromaDex (CDXC) United States $0.244B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.237B 0.00
Clearside Biomedical (CLSD) United States $0.233B 0.00
Allena Pharmaceuticals (ALNA) United States $0.225B 0.00
Kamada (KMDA) Israel $0.211B 16.41
Aeglea BioTherapeutics (AGLE) United States $0.211B 0.00
Protagonist Therapeutics (PTGX) United States $0.203B 0.00
Liquidia Technologies (LQDA) United States $0.203B 0.00
Spero Therapeutics (SPRO) United States $0.202B 0.00
Idera Pharmaceuticals (IDRA) United States $0.201B 0.00
Agenus (AGEN) United States $0.198B 0.00
Enzo Biochem (ENZ) United States $0.192B 0.00
Synlogic (SYBX) United States $0.191B 0.00
Menlo Therapeutics (MNLO) United States $0.186B 0.00
Palatin Technologies (PTN) United States $0.182B 7.03
Erytech Pharma SA Sponsored ADR (ERYP) $0.181B 0.00
TOCAGEN INC (TOCA) United States $0.179B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.177B 0.00
MannKind (MNKD) United States $0.177B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.176B 0.00
Signal Genetics (MGEN) United States $0.175B 0.00
Mustang Bio (MBIO) United States $0.170B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.169B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.165B 0.00
Krystal Biotech (KRYS) United States $0.165B 0.00
Cue Biopharma (CUE) United States $0.164B 0.00
BioDelivery Sciences (BDSI) United States $0.158B 0.00
Compugen (CGEN) Israel $0.156B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.156B 0.00
XBiotech (XBIT) United States $0.154B 0.00
OVID THERAPEUTC (OVID) United States $0.149B 0.00
BioXcel Therapeutics (BTAI) United States $0.144B 0.00
Intec Pharma (NTEC) Israel $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.137B 0.00
XOMA (XOMA) United States $0.136B 14.33
Cerecor (CERC) United States $0.133B 16.33
Provention Bio (PRVB) United States $0.125B 0.00
Anavex Life Sciences (AVXL) United States $0.125B 0.00
Organovo Holdings (ONVO) United States $0.124B 0.00
Trevena (TRVN) United States $0.123B 0.00
Catalyst Biosciences (CBIO) United States $0.121B 0.00
Monster Digital (INNT) United States $0.120B 0.00
Checkpoint Therapeutics (CKPT) United States $0.119B 0.00
Cidara Therapeutics (CDTX) United States $0.118B 0.00
VBI Vaccines (VBIV) United States $0.117B 0.00
Motif Bio Plc (MTFB) United States $0.117B 0.00
Cocrystal Pharma (COCP) United States $0.117B 0.00
PSivida (EYPT) United States $0.116B 0.00
Fortress Biotech (FBIO) United States $0.115B 0.00
Pfenex (PFNX) United States $0.114B 0.00
Aptevo Therapeutics (APVO) United States $0.114B 0.00
NewLink Genetics (NLNK) United States $0.112B 0.00
Tapimmune (TPIV) United States $0.106B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.102B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.101B 0.00
Orgenesis (ORGS) United States $0.101B 0.00
Aptose Biosciences (APTO) Canada $0.101B 0.00
Leap Therapeutics (LPTX) United States $0.100B 0.00
Asterias Biotherapeutics (AST) United States $0.097B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.094B 0.00
Proteostasis Therapeutics (PTI) United States $0.092B 0.00
Eleven Biotherapeutics (SESN) United States $0.091B 0.00
Alcobra (ARCT) Israel $0.086B 0.00
Ophthotech (OPHT) United States $0.085B 0.55
ScPharmaceuticals (SCPH) United States $0.084B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.083B 0.00
Oncolytics Biotech (ONCY) Canada $0.079B 0.00
Sophiris Bio (SPHS) United States $0.079B 0.00
Advaxis (ADXS) United States $0.078B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.077B 0.00
OncoSec Medical (ONCS) United States $0.076B 0.00
Histogenics (HSGX) United States $0.075B 0.00
Evogene (EVGN) Israel $0.074B 0.00
Protalix BioTherapeutics (PLX) Israel $0.073B 0.00
Applied Genetic Technologies (AGTC) United States $0.072B 0.00
Prima BioMed (IMMP) Australia $0.072B 0.00
VIVUS (VVUS) United States $0.071B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.069B 0.00
Celldex Therapeutics (CLDX) United States $0.068B 0.00
Alimera Sciences (ALIM) United States $0.064B 0.00
Axsome Therapeutics (AXSM) United States $0.063B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Novelion Therapeutics (NVLN) Canada $0.059B 0.00
VolitionRX (VNRX) Singapore $0.057B 0.00
Eyenovia (EYEN) United States $0.056B 0.00
Neothetics (EVFM) United States $0.055B 0.00
Curis (CRIS) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.050B 0.00
Caladrius Biosciences (CLBS) United States $0.050B 0.00
Zosano Pharma (ZSAN) United States $0.049B 0.00
CorMedix Inc (CRMD) United States $0.049B 0.00
Celsion (CLSN) United States $0.049B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
VTv Therapeutics (VTVT) United States $0.042B 0.00
Proteon Therapeutics (PRTO) United States $0.041B 0.00
AZURRX BIOPHARM (AZRX) United States $0.040B 0.00
Chiasma (CHMA) United States $0.040B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
Bellerophon Therapeutics (BLPH) United States $0.037B 0.00
CytRx (CYTR) United States $0.037B 0.00
GENPREX INC (GNPX) United States $0.037B 0.00
TRACON Pharmaceuticals (TCON) United States $0.036B 0.00
Aileron Therapeutics (ALRN) United States $0.033B 0.00
BioPharmX (BPMX) United States $0.033B 0.00
AquaBounty Technologies (AQB) United States $0.032B 0.00
AEterna Zentaris (AEZS) United States $0.030B 61.67
Benitec Biopharma (BNTC) Australia $0.030B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Vical (VICL) United States $0.029B 0.00
Edge Therapeutics (EDGE) United States $0.028B 0.00
OvaScience (OVAS) United States $0.028B 0.00
Oncobiologics (ONS) United States $0.027B 0.00
Cellect Biotechnology (APOP) Israel $0.026B 0.00
Arsanis (ASNS) United States $0.026B 0.00
Cel-Sci (CVM) United States $0.024B 0.00
Soligenix (SNGX) United States $0.024B 0.00
Gemphire Therapeutics (GEMP) United States $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
Adial Pharmaceuticals (ADIL) United States $0.022B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
ATyr Pharma (LIFE) United States $0.019B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
RestorGenex (DFFN) United States $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.019B 0.00
AmpliPhi Biosciences (APHB) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Neuralstem (CUR) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.013B 6.47
Synthetic Biologics (SYN) United States $0.012B 0.00
Flex Pharma (FLKS) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Galena Biopharma (SLS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
IBio (IBIO) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Oragenics (OGEN) United States $0.003B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.002B 0.00
Aytu Bioscience (AYTU) United States $0.001B 0.00